Muscle expression levels of Ppargc1a and Slc2a4 were induced or trended so in the HF control group, and induction of these genes was counteracted in the BC group and potentiated in the groups receiving MET, alone or combined with BC. The gene discussed is PPARGC1A; the disease is breast cancer.